ArticleJournal of market access & health policy2026
Validation of a De Novo Health Economic Model for Finerenone in Heart Failure with Left Ventricular Ejection Fraction ≥40.
Tobiasz Lemański et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.